BePharma 2026

BePharma: The Leading B2B Pharmaceutical Networking Event in the Americas

BePharma is one of the most important B2B pharmaceutical events in the Americas, bringing together companies from the pharmaceutical and broader healthcare sectors to build strategic partnerships and develop international business opportunities. Held annually in Mexico City, the event has established itself as a specialized networking platform where manufacturers, distributors, suppliers, licensors, and healthcare organizations connect through structured business meetings rather than a traditional exhibition format. By focusing on targeted commercial interactions, BePharma enables companies to accelerate partnerships, expand into new markets, and strengthen their global presence.

A business-focused platform for the pharmaceutical industry

The pharmaceutical industry is increasingly shaped by global cooperation, where companies rely on international partners for manufacturing, distribution, research, licensing, and product development. In this context, BePharma was designed as a highly efficient environment dedicated exclusively to business negotiations.

Unlike conventional trade fairs, BePharma does not rely on open exhibition halls or random networking. Instead, it uses a structured system of pre-arranged B2B meetings based on aligned business interests. This format allows participants to focus on relevant discussions with potential partners, whether they are seeking distributors, contract manufacturers, API suppliers, or licensing opportunities.

For more than eight years, the event has supported structured collaboration between companies across the global healthcare ecosystem, helping decision-makers establish meaningful commercial relationships in a focused and professional setting.

Bringing together the global healthcare ecosystem

BePharma gathers participants from all stages of the pharmaceutical value chain, creating a diverse environment that supports cooperation across multiple healthcare sectors. The event combines established global companies with growing regional players, encouraging international collaboration and knowledge exchange.

Participants typically include

• Pharmaceutical manufacturers
• Wholesalers and distribution companies
• API and raw material suppliers
• Contract manufacturing organizations (CMOs)
• Licensing and business development firms
• Biotechnology companies
• Laboratory and diagnostic service providers
• Healthcare technology and service providers

This broad participation allows companies to explore opportunities in manufacturing, product sourcing, licensing agreements, regulatory cooperation, and international expansion strategies.

By connecting organizations from different regions, BePharma acts as a gateway for companies seeking to enter or expand within Latin American healthcare markets, while also enabling local businesses to build global partnerships.

Structured B2B meetings that drive real business outcomes

The defining feature of BePharma is its highly organized meeting system. Instead of relying on spontaneous conversations, participants schedule meetings in advance based on shared commercial interests and strategic goals.

Each edition brings together more than 150 companies and generates over 11,000 pre-arranged business meetings. Since its creation, BePharma has facilitated cooperation between more than 850 companies from over 50 countries, resulting in more than 10,000 structured B2B negotiations.

This approach offers several key advantages

• Efficient use of time through scheduled meetings
• Direct access to senior executives and decision-makers
• Higher quality business discussions focused on real needs
• Faster identification of partners and suppliers
• Increased opportunities for international expansion

Because every meeting is purpose-driven, participants can focus entirely on negotiations that have clear commercial potential, rather than spending time on general networking.

Supporting international growth in healthcare

As the pharmaceutical industry becomes more interconnected, cross-border collaboration has become essential for innovation and growth. BePharma plays an important role in facilitating this cooperation by connecting companies involved in manufacturing, research, technology transfer, and commercialization.

The event is particularly valuable for organizations seeking expansion into Latin America. International companies gain access to regional distributors and healthcare networks, while Latin American firms connect with global manufacturers, licensors, and technology providers.

Beyond pharmaceuticals, the event also supports collaboration in related healthcare fields, including biotechnology, laboratory services, medical technologies, and healthcare innovation. This broader ecosystem encourages partnerships that extend beyond traditional pharmaceutical business models.

Why professionals attend BePharma

BePharma attracts pharmaceutical and healthcare executives because it delivers measurable business value through structured networking and targeted meetings.

Participants attend to

• Meet pharmaceutical manufacturers, distributors, and suppliers
• Explore licensing and strategic partnership opportunities
• Identify international partners for market expansion
• Build long-term relationships across the healthcare sector
• Conduct efficient, results-oriented B2B negotiations

These opportunities are valuable for pharmaceutical companies, biotech firms, contract manufacturers, laboratory specialists, licensing experts, investors, consultants, and healthcare organizations seeking strategic growth.

As one of the leading pharmaceutical partnering events in the Americas, BePharma continues to strengthen its position as a key platform for international collaboration. Its structured meeting format, global participation, and strong business focus make it an essential environment for organizations aiming to expand their presence, develop strategic alliances, and accelerate growth within the global healthcare industry.